124 related articles for article (PubMed ID: 23909477)
1. Blood transfusion in cardiac surgery does increase the risk of 5-year mortality: results from a contemporary series of 1714 propensity-matched patients.
Shaw RE; Johnson CK; Ferrari G; Brizzio ME; Sayles K; Rioux N; Zapolanski A; Grau JB
Transfusion; 2014 Apr; 54(4):1106-13. PubMed ID: 23909477
[TBL] [Abstract][Full Text] [Related]
2. Impact of blood product transfusion on short and long-term survival after cardiac surgery: more evidence.
Bhaskar B; Dulhunty J; Mullany DV; Fraser JF
Ann Thorac Surg; 2012 Aug; 94(2):460-7. PubMed ID: 22626751
[TBL] [Abstract][Full Text] [Related]
3. Transfusion of blood during cardiac surgery is associated with higher long-term mortality in low-risk patients.
Jakobsen CJ; Ryhammer PK; Tang M; Andreasen JJ; Mortensen PE
Eur J Cardiothorac Surg; 2012 Jul; 42(1):114-20. PubMed ID: 22241009
[TBL] [Abstract][Full Text] [Related]
4. Platelet transfusion in cardiac surgery does not confer increased risk for adverse morbid outcomes.
McGrath T; Koch CG; Xu M; Li L; Mihaljevic T; Figueroa P; Blackstone EH
Ann Thorac Surg; 2008 Aug; 86(2):543-53. PubMed ID: 18640332
[TBL] [Abstract][Full Text] [Related]
5. The effect of erythrocyte blood transfusions on survival after surgery for hip fracture.
Engoren M; Mitchell E; Perring P; Sferra J
J Trauma; 2008 Dec; 65(6):1411-5. PubMed ID: 19077635
[TBL] [Abstract][Full Text] [Related]
6. Outcome of patients who refuse transfusion after cardiac surgery: a natural experiment with severe blood conservation.
Pattakos G; Koch CG; Brizzio ME; Batizy LH; Sabik JF; Blackstone EH; Lauer MS
Arch Intern Med; 2012 Aug; 172(15):1154-60. PubMed ID: 22751620
[TBL] [Abstract][Full Text] [Related]
7. Morbidity and mortality after massive transfusion in patients undergoing non-cardiac surgery.
Turan A; Yang D; Bonilla A; Shiba A; Sessler DI; Saager L; Kurz A
Can J Anaesth; 2013 Aug; 60(8):761-70. PubMed ID: 23609882
[TBL] [Abstract][Full Text] [Related]
8. Aprotinin in cardiac surgery patients: is the risk worth the benefit?
Stamou SC; Reames MK; Skipper E; Stiegel RM; Nussbaum M; Geller R; Robicsek F; Lobdell KW
Eur J Cardiothorac Surg; 2009 Nov; 36(5):869-75. PubMed ID: 19782574
[TBL] [Abstract][Full Text] [Related]
9. Balancing the benefits and risks of blood transfusions in patients undergoing cardiac surgery: a propensity-matched analysis.
Shaw RE; Johnson CK; Ferrari G; Zapolanski A; Brizzio M; Rioux N; Edara S; Sperling J; Grau JB
Interact Cardiovasc Thorac Surg; 2013 Jul; 17(1):96-102. PubMed ID: 23537850
[TBL] [Abstract][Full Text] [Related]
10. Impact of postoperative nadir hemoglobin and blood transfusion on outcomes after operations for atherosclerotic vascular disease.
Kougias P; Orcutt S; Pak T; Pisimisis G; Barshes NR; Lin PH; Bechara CF
J Vasc Surg; 2013 May; 57(5):1331-7; discussion. PubMed ID: 23384496
[TBL] [Abstract][Full Text] [Related]
11. Blood transfusion during acute myocardial infarction: association with mortality and variability across hospitals.
Salisbury AC; Reid KJ; Marso SP; Amin AP; Alexander KP; Wang TY; Spertus JA; Kosiborod M
J Am Coll Cardiol; 2014 Aug; 64(8):811-9. PubMed ID: 25145526
[TBL] [Abstract][Full Text] [Related]
12. The effect of the Cox-maze procedure for atrial fibrillation concomitant to mitral and tricuspid valve surgery.
Ad N; Holmes SD; Massimiano PS; Pritchard G; Stone LE; Henry L
J Thorac Cardiovasc Surg; 2013 Dec; 146(6):1426-34; discussion 1434-5. PubMed ID: 24075462
[TBL] [Abstract][Full Text] [Related]
13. Comparisons of cardiac surgery outcomes in Jehovah's versus Non-Jehovah's Witnesses.
Stamou SC; White T; Barnett S; Boyce SW; Corso PJ; Lefrak EA
Am J Cardiol; 2006 Nov; 98(9):1223-5. PubMed ID: 17056333
[TBL] [Abstract][Full Text] [Related]
14. Effect of peri-operative red blood cell transfusion on 30-day and 1-year mortality following coronary artery bypass surgery.
Kuduvalli M; Oo AY; Newall N; Grayson AD; Jackson M; Desmond MJ; Fabri BM; Rashid A
Eur J Cardiothorac Surg; 2005 Apr; 27(4):592-8. PubMed ID: 15784356
[TBL] [Abstract][Full Text] [Related]
15. Blood transfusion determines postoperative morbidity in pediatric cardiac surgery applying a comprehensive blood-sparing approach.
Redlin M; Kukucka M; Boettcher W; Schoenfeld H; Huebler M; Kuppe H; Habazettl H
J Thorac Cardiovasc Surg; 2013 Sep; 146(3):537-42. PubMed ID: 23228399
[TBL] [Abstract][Full Text] [Related]
16. Debunking the survival bias myth: characterization of mortality during the initial 24 hours for patients requiring massive transfusion.
Brown JB; Cohen MJ; Minei JP; Maier RV; West MA; Billiar TR; Peitzman AB; Moore EE; Cushieri J; Sperry JL;
J Trauma Acute Care Surg; 2012 Aug; 73(2):358-64; discussion 364. PubMed ID: 22846940
[TBL] [Abstract][Full Text] [Related]
17. Bloodless cardiac surgery is associated with decreased morbidity and mortality.
Whitson BA; Huddleston SJ; Savik K; Shumway SJ
J Card Surg; 2007; 22(5):373-8. PubMed ID: 17803571
[TBL] [Abstract][Full Text] [Related]
18. Association of complications with blood transfusions in pediatric cardiac surgery patients.
Iyengar A; Scipione CN; Sheth P; Ohye RG; Riegger L; Bove EL; Devaney EJ; Hirsch-Romano JC
Ann Thorac Surg; 2013 Sep; 96(3):910-6. PubMed ID: 23866807
[TBL] [Abstract][Full Text] [Related]
19. Risks and predictors of blood transfusion in pediatric patients undergoing open heart operations.
Székely A; Cserép Z; Sápi E; Breuer T; Nagy CA; Vargha P; Hartyánszky I; Szatmári A; Treszl A
Ann Thorac Surg; 2009 Jan; 87(1):187-97. PubMed ID: 19101294
[TBL] [Abstract][Full Text] [Related]
20. Fresh-frozen plasma transfusion did not reduce 30-day mortality in patients undergoing cardiopulmonary bypass cardiac surgery with excessive bleeding: the PLASMACARD multicenter cohort study.
Doussau A; Perez P; Puntous M; Calderon J; Jeanne M; Germain C; Rozec B; Rondeau V; Chêne G; Ouattara A; Janvier G;
Transfusion; 2014 Apr; 54(4):1114-24. PubMed ID: 24117772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
